RGEN

Repligen Corporation (RGEN), based in Waltham, Massachusetts, is a premier provider of advanced bioprocessing technologies that streamline the development and production of biologic drugs. Serving a diverse global clientele across North America, Europe, and the Asia Pacific, Repligen's comprehensive solutions encompass both upstream and downstream processes, positioning the company as a key player in the biopharmaceutical industry. With a strong commitment to innovation and product quality, Repligen is strategically poised to capture growth opportunities emerging from the rising demand for biologics driven by cutting-edge therapeutic advancements and robust investment within the biopharmaceutical sector.